Ipriflavone

MUSCULO-SKELETAL SYSTEM

Key facts

Ipriflavone is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including HDAC6, SLC6A2 and PTGS1. Recorded indications include Postmenopausal osteoporosis.

• Molecular targets: HDAC6, SLC6A2 and PTGS1 (3 listed in DrugCentral).
• Indications: Postmenopausal osteoporosis.
• ATC code: M05BX01 (Other drugs affecting bone structure and mineralization).
• Molecular formula: C18H16O3; molecular weight 280.32 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Postmenopausal osteoporosis

Mechanism & targets

Molecular targets (3)

Target	Gene	Action	Activity
Histone deacetylase 6	HDAC6	unknown	IC50 6.04
Sodium-dependent noradrenaline transporter	SLC6A2	unknown	Ki 5.60
Prostaglandin G/H synthase 1	PTGS1	unknown	IC50 5.53

ATC classification

ATC code	Therapeutic hierarchy
M05BX01	MUSCULO-SKELETAL SYSTEM › DRUGS FOR TREATMENT OF BONE DISEASES › DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION › Other drugs affecting bone structure and mineralization

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ipriflavone is on its molecule page.

• Molecular formula: C₁₈H₁₆O₃
• Molecular weight: 280.32 g/mol
• CAS number: 35212-22-7
• InChIKey: SFBODOKJTYAUCM-UHFFFAOYSA-N
• PubChem CID: 3747

CC(C)OC1=CC=C2C(=O)C(=COC2=C1)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ipriflavone used for?

DrugCentral lists the following indications for Ipriflavone: Postmenopausal osteoporosis.

How does Ipriflavone work?

Its molecular targets in DrugCentral include HDAC6, SLC6A2 and PTGS1.

What is the chemical formula of Ipriflavone?

Ipriflavone has the molecular formula C18H16O3 and a molecular weight of 280.32 g/mol.

Sources

• DrugCentral drug card 1477 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL165790 — compound record and bioactivity
• PubChem CID 3747 — chemical identifiers
• DrugBank DB13618 — drug record
• FDA UNII 80BJ7WN25Z — substance identity
• UniProt Q9UBN7 (HDAC6) — target protein
• UniProt P23975 (SLC6A2) — target protein
• UniProt P23219 (PTGS1) — target protein

How this page is built: methodology · editorial policy & corrections.